InsiderClue
Stocks · Health care · Pharmaceutical Preparations

NEKTAR THERAPEUTICS

NKTR Clue Score14
United States Fiscal year ends December CIK 0000906709 Results filed 13 Aug 2026
Add to watchlist

What the insiders did Net selling

Individual transactions

9
Insider
Date
Role
Action
Shares
Price
Amount
R Scott Greer
9 Nov 2021
Director
Exercised, kept
12,500
$12.80
$160.00K
Roy A Whitfield
16 Sep 2021
Director
Exercised, kept
40,000
$13.80
$552.00K
R Scott Greer
31 Aug 2021
Director
Exercised, kept
45,000
$12.70
$571.50K
R Scott Greer
5 Jan 2021
Director
Exercised, kept
40,000
$13.80
$552.00K
Roy A Whitfield
4 Sep 2020
Director
Exercised, kept
30,000
$9.24
$277.20K
Roy A Whitfield
18 Dec 2019
Director
Exercised, kept
10,000
$9.24
$92.40K
Gil M Labrucherie
26 Aug 2019
SVP & Chief Financial Officer
Exercised, kept
30,000
$16.31
$489.30K
Howard W Robin
23 Aug 2019
President & CEO
Exercised, kept
30,000
$16.31
$489.30K
R Scott Greer
8 Mar 2019
Director
Exercised, kept
10,000
$5.14
$51.40K
Showing 250 of 382 transactions. The figures above use every one of them.

What was left out

Form 4 filings counted 431
Amendments (4/A) skipped 8
Filings about a different issuer 0
Unreadable filings 0
Joint filings 1
Sales on a Rule 10b5-1 plan 27
Sales straight out of an exercise 122
Sales at will 212
Transactions with no price 0
Shares from compensation/vesting 10,057,054
Sales filed before the plan box existed 165
History held since 7 Nov 2006